OrthoPediatrics (KIDS) reported Monday preliminary Q4 net revenue of $52.7 million, up from $37.6 million a year earlier.
Analysts polled by FactSet expect $50.7 million.
The company expects 2025 revenue of $235 million to $242 million, up 15% to 18% from the preliminary figure of $204.7 million.
Analysts surveyed by FactSet project $239.9 million.
OrthoPediatrics plans to release Q4 and 2024 results in early March.
Price: 25.44, Change: +0.44, Percent Change: +1.76
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.